Description
A saponin with diverse biological activities; induces proliferation, migration, and tube formation of HUVECs in an mTOR-dependent manner; induces cell cycle arrest at the S and G2/M phases and promotes apoptosis of SH-SY5Y cells at 45 μM; increases cGMP levels and induces relaxation of isolated precontracted rat mesenteric arteries; promotes angiogenesis and decreases wound diameter in a mouse model of punched-hole ear injury at 0.25, 2.5, and 25 mg/kg; decreases tail bleeding time and increases thrombus weight in a rat tail bleeding assay at 1.25 mg/kg; increases mRNA expression of collagen expression, fibroblast proliferation, and scar formation genes; promotes neovascularization, reduces monocyte infiltration, and shortens wound closure time in a db/db mouse model of diabetic foot ulcers
Formal name: (3β,12β,20R)-12,20-dihydroxydammar-24-en-3-yl O-β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside
Synonyms:
Molecular weight: 917.1
CAS: 155683-00-4
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Saponins||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Cardiovascular System|Vasculature|Angiogenesis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes